跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DEPREVIX MODIFIED RELEASE HARD CAPSULE 150MG - HSA Drug Approval Details
Approvals
/
HSA
/
DEPREVIX MODIFIED RELEASE HARD CAPSULE 150MG
Approved
THERAPEUTIC
DEPREVIX MODIFIED RELEASE HARD CAPSULE 150MG
PHARMATHEN S.A. - GREECEPHARMATHEN INTERNATIONAL S.A. (GREECE)
🇸🇬 Health Sciences Authority
Approval Date
Aug 8, 2018
Approval ID
1c4fc1c0f19cf92c
Company
PHARMATHEN S.A. - GREECEPHARMATHEN INTERNATIONAL S.A. (GREECE)
Type
Therapeutic
Approval Details
Approval Id
1c4fc1c0f19cf92c
Drug Name
DEPREVIX MODIFIED RELEASE HARD CAPSULE 150MG
Product Name
DEPREVIX MODIFIED RELEASE HARD CAPSULE 150MG
Approval Number
SIN15521P
Approval Date
2018-08-08
Registrant
SEA PHARMA CONSULTANCY PTE LTD
Licence Holder
SEA PHARMA CONSULTANCY PTE LTD
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
CAPSULE, DELAYED RELEASE
Route Of Administration
ORAL
Atc Code
N06AX16
Atc Item Name
venlafaxine
Pharma Manufacturer Name
SEA PHARMA CONSULTANCY PTE. LTD.
Company Detail Path
/organization/sea-pharma-consultancy-pte-ltd
Active Ingredients
Venlafaxine Hydrochloride 169.71mg eqv Venlafaxine
150mg
Venlafaxine Hydrochloride 169.71mg eqv Venlafaxine
150mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Aug 8, 2018
Approval ID
1c4fc1c0f19cf92c
Type
Therapeutic
Back to HSA Approvals
